Rapt Therapeutics Moon Shot Potential

NASDAQ:RAPT   RAPT Therapeutics, Inc.
Since coming public at $12.00, on 10/31/19
Rapt Therapeutics ( RAPT ) has been under accumulation,
with the stock has rising to $42,and now after a recent triangle breakout, trading above 30

This company out of San Francisco,Ca is working on genetic cancer cure drugs.
The potential for long term stock appreciation is very significant.
but with any endeavor of this kind comes substantial risks.

Disclosure :I have owned Rapt since the IPO at 12.00,
and have been accumulating the stock on any pullbacks.
You must be able to accept large bid/ask spread with this stock,and low volume

However, the reward potential here far outweighs the risks in my opinion.

RAPT could easily triple from the current price, when the company's
two patented phase one drugs show significant progress in current test results.

Strong Recommendation : Buy Rapt. Then hold on tight.
A potential gain of 300% from these levels, in time could easily be your reward.

RAPT 30.78 Last



The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.